Post by stcks on Aug 26, 2018 16:55:51 GMT
A Shot of Competition for EpiPen
The FDA removes a barrier to approval of ‘complex generics.’
A couple of years ago Washington fell into anaphylactic shock over the high cost of EpiPens, devices that shoot adrenaline into someone having an allergic reaction. But the Trump Administration this week injected some overdue competition into the market that could lower prices for millions of Americans.
www.wsj.com/articles/a-shot-of-competition-for-epipen-1534716945
The FDA removes a barrier to approval of ‘complex generics.’
A couple of years ago Washington fell into anaphylactic shock over the high cost of EpiPens, devices that shoot adrenaline into someone having an allergic reaction. But the Trump Administration this week injected some overdue competition into the market that could lower prices for millions of Americans.
www.wsj.com/articles/a-shot-of-competition-for-epipen-1534716945